Oxaliplatin (Breckenridge Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the Oxaliplatin drug offered from Breckenridge Pharmaceutical, Inc.. This Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Breckenridge Pharmaceutical, Inc. |
| NON-PROPRIETARY NAME: | Oxaliplatin |
| SUBSTANCE NAME: | OXALIPLATIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-09-01 |
| END MARKETING DATE: | 0000-00-00 |
Oxaliplatin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Oxaliplatin from Breckenridge Pharmaceutical, Inc. |
| LABELER NAME: | Breckenridge Pharmaceutical, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/10mL) |
| START MARKETING DATE: | 2017-09-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51991-218_f8a6be44-f539-45e1-9073-ce7ded3d3d2e |
| PRODUCT NDC: | 51991-218 |
| APPLICATION NUMBER: | ANDA204616 |
Other OXALIPLATIN Pharmaceutical Manufacturers / Labelers:
